We are live on ! Find out more
VINC

Vincerx Pharma, Inc. Common Stock

Delisted

VINC was delisted on the 22nd of April, 2025.

Name Holding Trade Value Shares
Change
Change in
Stake
Goldman Sachs
1
Goldman Sachs
New York
$2.15M -$10.5K -469 -0.5%
SRC
2
Sage Rhino Capital
California
$1.75M
AAA
3
Affinity Asset Advisors
New York
$1.55M
LFCM
4
Long Focus Capital Management
Puerto Rico
$1.47M
RSCM
5
Rock Springs Capital Management
Maryland
$927K
SSA
6
Schonfeld Strategic Advisors
New York
$656K +$64.6K +2,884 +10%
Citadel Advisors
7
Citadel Advisors
Florida
$649K
Vanguard Group
8
Vanguard Group
Pennsylvania
$541K
ECM
9
ExodusPoint Capital Management
New York
$407K +$158K +7,037 +56%
RCMNY
10
Rubric Capital Management (New York)
New York
$402K
KCM
11
Kingdon Capital Management
New York
$400K
SM
12
Sabby Management
Florida
$368K -$164K -7,330 -29%
Point72 Asset Management
13
Point72 Asset Management
Connecticut
$359K +$560 +25 +0.1%
TC
14
Tejara Capital
United Kingdom
$303K -$22.4K -1,000 -6%
BBA
15
Baker Bros. Advisors
New York
$251K
Renaissance Technologies
16
Renaissance Technologies
New York
$203K +$15.7K +700 +8%
Geode Capital Management
17
Geode Capital Management
Massachusetts
$142K
BlackRock
18
BlackRock
New York
$119K -$27.1K -1,209 -17%
SCM
19
Sio Capital Management
New York
$106K
TCM
20
Tang Capital Management
California
$106K
CC
21
Clearline Capital
New York
$103K
Millennium Management
22
Millennium Management
New York
$89K +$16.9K +755 +22%
LP
23
LMR Partners
United Kingdom
$62.4K
State Street
24
State Street
Massachusetts
$44.9K
Acadian Asset Management
25
Acadian Asset Management
Massachusetts
$42K